Most common regimens prescribed for treatment of GDM included insulin (NPH/Regular 70/30) by 64 (30.5%), insulin (NPH/Regular in split regimes) by 60 (28.6%), a combination of insulin and oral anti-diabetic drugs by 35 (16.7%), oral anti-diabetic agents by 37 (17.6%), basal insulin only by 11 (5.2%) and basal plus ultra-short acting insulin by 3 (1.4%) respondents.(Table-IV). This evidence concerns the gene INS and gestational diabetes.